Favismo
Revisado por Dr Hannah Gronow, MBACPÚltima actualización por Dr Louise Newson, MRCGPÚltima actualización 21 Sept 2015
Cumple con las directrices editoriales
- DescargarDescargar
- Compartir
- Language
- Discusión
- Ask Patient
- Versión en audio
- Agregar a fuentes preferidas en Google
Aviso sobre el contenido
Esta página no se ha revisado recientemente, por lo que es posible que haya cambiado parte de la información o que algunos enlaces externos ya no funcionen.
Profesionales Médicos
Los artículos de Referencia Profesional están diseñados para ser utilizados por profesionales de la salud. Están escritos por médicos del Reino Unido y se basan en evidencia de investigación, así como en guías del Reino Unido y Europa. Puede encontrar uno de nuestros artículos de salud más útil.
Ver también separado Glucose-6-phosphate Dehydrogenase Deficiency artículo.
Favism describes the susceptibility to, and clinical presentation of, acute haemolytic crises as a consequence of eating broad beans in a subgroup of patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency.
It can be potentially life-threatening. Broad beans are derived from the plant Vicia fava - hence, the condition's name. Susceptible patients may also experience the syndrome when exposed to the plant's pollen.
G6PD is crucial in maintaining red cell homeostasis and its deficiency leads to increased susceptibility to haemolysis induced by drugs, infections and substances in food. There is a huge number of polymorphisms of the gene with variable effects on the activity of the enzyme and a wide range of phenotypic susceptibility to haemolysis.
Genética
The gene for G6PD is located on the X chromosome. It is therefore an X-linked inherited disease that primarily affects men. It can have clinical effects in homozygous women and a proportion of female heterozygous carriers.
It is thought that the susceptibility to favism is determined by a combination of the particular G6PD polymorphism and other factors, such as genetics and also metabolism of the active ingredients in the beans, which causes oxidative damage in red blood cells. An infectious agent such as a virus may also play a role in the development of favism.1
Epidemiología
G6PD deficiency is the most common enzymopathy of man of clinical significance. It affects more than 400 million people worldwide.2
Patients with favism are always G6PD-deficient but not all G6PD-deficient individuals develop haemolysis when they ingest fava beans.
The vast majority of cases of favism occur in individuals with severely deficient variants of G6PD.
Favism is more common in males than in females.3
Presentación
There may be a past history of episodes of neonatal or childhood jaundice.
A dietary history may reveal recent ingestion of broad beans.
Check for recent medication changes or history consistent with infection.
Favism leads to acute, massive intravascular haemolysis. Its main clinical features are:
Acute back and/or abdominal pain.
Acute pallor due to anaemia.
Haemoglobinuria causing the passage of dark or orangey-yellow urine.
Ictericia.
Patients with G6PD deficiency are prone to gallstones and splenomegaly due to recurrent, often subclinical, episodes of haemolysis.
Diagnóstico diferencial
Acute haemolysis caused by an alternative precipitant in those with G6PD deficiency - eg, drugs, particularly antimalarials or infection.
Exacerbation of other haemolytic anaemias - eg, esferocitosis hereditaria, autoimmune haemolytic anaemia.
Investigaciones
Dipstick urine testing to reveal evidence of haemoglobinuria.
FBC will show acute haemolytic anaemia picture with low haemoglobin.
Reticulocyte count may be elevated (although often normal in the early acute phase).
Raised indirect bilirubin (unconjugated) indicating haemolysis.
LFTs are usually normal.
Serum lactate dehydrogenase may be elevated, indicating haemolysis.
Serum haptoglobins may be low, indicating haemolysis.
Abdominal ultrasound may be used to detect gallstones and/or splenomegaly.
Coombs' test is negative.
G6PD activity assay in undiagnosed cases - may be normal if there is significant reticulocytosis, as reticulocytes are rich in the enzyme; assay may need to be repeated in the convalescent phase.
Enfermedades asociadas
Cálculos biliares due to chronic haemolysis.
Esplenomegalia due to chronic haemolysis.
Manejo
Avoid further ingestion of broad beans.
Folic acid supplementation.
Iron supplementation if there is ongoing acute severe intravascular haemolysis.
Oxygen therapy.
Bed rest and transfer to a high care/intensive care setting.
Intravenous fluids to reduce the chance of acute oliguric renal impairment.
Blood transfusion or exchange transfusion is sometimes needed to treat severe anaemia.
Complicaciones
Death due to acute severe haemolytic anaemia (relatively rare).
Ophthalmological damage due to intraocular intravascular haemolysis.
Susceptibility to infection.
Pronóstico
This is variable depending on the degree of susceptibility to favism, quantity of beans ingested and access to acute medical care. Most cases do well with supportive care but there is significant morbidity and some mortality associated with the disease.
Prevención
Avoidance of ingestion of broad beans in patients known to have G6PD deficiency, or who have suffered previous episodes of favism.
However, one study found that the majority of patients who ate fava beans after an attack had no symptoms.1.
Asesoramiento genético and screening may be useful where there is a family history of G6PD deficiency, to allow diagnosis before exposure to haemolytic precipitants.
Population screening and health education programmes in areas of high prevalence of G6PD deficiency have been shown to reduce the incidence of favism in the at-risk population.4
See separate article on G6PD deficiency for a list of medications to be avoided in G6PD-deficient patients.
Actualizaciones exclusivas para profesionales de la salud
Mantente informado con las últimas actualizaciones clínicas, perspectivas profesionales y orientación basada en evidencia. El boletín de Patient Pro selecciona contenido esencial para profesionales de la salud, entregado directamente en tu bandeja de entrada.
Al suscribirte aceptas nuestros Política de Privacidad. Puedes darte de baja en cualquier momento. Nunca vendemos tus datos.
Lecturas adicionales y referencias
- Ahmed SN; Do favic patients resume fava beans ingestion later in their life, a study for this, and a new hypothesis for favism etiology. Hematol Oncol Stem Cell Ther. 2013 Mar;6(1):9-13. doi: 10.1016/j.hemonc.2013.03.002. Epub 2013 Mar 22.
- Osman HG, Zahran FM, El-Sokkary AM, et al; Identification of Mediterranean mutation in Egyptian favism patients. Eur Rev Med Pharmacol Sci. 2014 Oct;18(19):2821-7.
- Osman HG, Zahran FM, El-Sokkary AM, et al; Oxidative stress and antioxidant defense in Egyptian favism patients. Eur Rev Med Pharmacol Sci. 2013 May;17(9):1211-7.
- Verma IC, Puri RD; Global burden of genetic disease and the role of genetic screening. Semin Fetal Neonatal Med. 2015 Aug 3. pii: S1744-165X(15)00078-5. doi: 10.1016/j.siny.2015.07.002.
Acerca del revisorVer biografía completa

Dr Hannah Gronow, MBACP
Médico General
MB, ChB, MBACP
Hannah se calificó como médica general en 1997. Se unió a EMIS (Paciente) como revisora por pares en agosto de 2006.
Más en hematología
- Infecciones antenatales y sus consecuencias
- Médula ósea y fallo de médula ósea
- Leucemia mieloide crónica
- Aglutininas frías
- Deficiencias del complemento
- Síndrome de Di Guglielmo
- Coagulación intravascular diseminada
- Deficiencia de glucosa-6-fosfato deshidrogenasa
- Hemodilución
- linfoma de Hodgkin
- Hiperlipidemia
- Sobrecarga de hierro
- Micosis fungoide y linfomas cutáneos de células T
- Síndrome de Osler-Weber-Rendu
- Paraproteinemia
- Mielofibrosis primaria
- Deficiencia de proteína C
- Inmunoglobulinas terapéuticas
- Púrpura trombocitopénica trombótica
- Enfermedad de Von Willebrand


